| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Dana-Farber Cancer Institute [S. B., M-S. C., D. A., Y. S., Y. W. W-K. W., J. Z., R. S., C. M-G., E. W., L. H., H. S., M. S. C., S-K. K., L. B. C.] and Beth Israel Deaconess Hospital [M. L.], Harvard Medical School, Boston, Massachusetts 02115, and Shionogi BioResearch Corporation, Lexington, Massachusetts 02421 [Y. L., X. Q., E. Y. S. C., K-M. L.]
Using the palindromic PCR-cDNA display method, we have cloned a novel gene overexpressed by human colon carcinoma relative to normal colon. Among normal tissues examined, only testis expresses it at a high level. Sequence analysis revealed its extensive homology with checkpoint genes rad17 of Schizosaccharomyces pombe and RAD24 of Saccharomyces cerevisiae. This novel gene designated as hRad17 is localized to chromosome 5q12,13.1, a region known to be deleted in a variety of human cancers. Promoter region and one pseudogene of hRad17 have been identified. Whereas the increased expression of hRad17 by human colon carcinomas may be related to the known resistance of these cells to DNA-damaging agents during therapy, the deletion of hRad17 in a variety of cancers may predispose them to increased rate of mutation and heightened sensitivity to DNA-damaging agents, including radiation and anticancer drugs.
This article has been cited by other articles:
![]() |
P Dey Aneuploidy and malignancy: an unsolved equation J. Clin. Pathol., December 1, 2004; 57(12): 1245 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Post, A. E. Tomkinson, and E. Y.-H. P. Lee The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase {epsilon} Nucleic Acids Res., October 1, 2003; 31(19): 5568 - 5575. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Post, Y.-C. Weng, K. Cimprich, L. B. Chen, Y. Xu, and E. Y.-H. P. Lee Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G1/S checkpoint activation in response to DNA damage PNAS, October 25, 2001; (2001) 231364598. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, L. Wang, M. D. Callister, J. B. Putnam, L. Mao, and L. Li Human Rad17 Is Phosphorylated upon DNA Damage and also Overexpressed in Primary Non-Small Cell Lung Cancer Tissues Cancer Res., October 1, 2001; 61(20): 7417 - 7421. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kataoka, N. Sadanaga, K. Mimori, H. Ueo, G. F. Barnard, K. Sugimachi, D. Auclair, L. B. Chen, and M. Mori Overexpression of HRad17 mRNA in Human Breast Cancer: Correlation with Lymph Node Metastasis Clin. Cancer Res., September 1, 2001; 7(9): 2815 - 2820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Chang, H. Sasaki, M. S. Campbell, S.-K. Kraeft, R. Sutherland, C.-Y. Yang, Y. Liu, D. Auclair, L. Hao, H. Sonoda, et al. HRad17 Colocalizes with NHP2L1 in the Nucleolus and Redistributes after UV Irradiation J. Biol. Chem., December 17, 1999; 274(51): 36544 - 36549. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Burtelow, S. H. Kaufmann, and L. M. Karnitz Retention of the Human Rad9 Checkpoint Complex in Extraction-resistant Nuclear Complexes after DNA Damage J. Biol. Chem., August 18, 2000; 275(34): 26343 - 26348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rauen, M. A. Burtelow, V. M. Dufault, and L. M. Karnitz The Human Checkpoint Protein hRad17 Interacts with the PCNA-like Proteins hRad1, hHus1, and hRad9 J. Biol. Chem., September 15, 2000; 275(38): 29767 - 29771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Burtelow, P. M. K. Roos-Mattjus, M. Rauen, J. R. Babendure, and L. M. Karnitz Reconstitution and Molecular Analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA Damage Responsive Checkpoint Complex J. Biol. Chem., July 6, 2001; 276(28): 25903 - 25909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Post, Y.-C. Weng, K. Cimprich, L. B. Chen, Y. Xu, and E. Y.-H. P. Lee Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G1/S checkpoint activation in response to DNA damage PNAS, November 6, 2001; 98(23): 13102 - 13107. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |